Journal of Fertility Biomarkers publishes rigorous fertility biomarker research that advances diagnosis, treatment, and reproductive outcomes.

Follow these guidelines to ensure a smooth editorial review and production process.

• Use clear, concise language and define all abbreviations
• Include structured abstracts with objectives, methods, results, and conclusions
• Provide keywords that reflect fertility biomarker types and methods
• Ensure references are complete and include DOIs where available

• STROBE for observational studies
• CONSORT for randomized trials
• PRISMA for systematic reviews
• CARE for case reports
• TREND for non randomized evaluations

• Include ethics approvals and informed consent statements
• Provide data availability statements and repository links
• Describe diagnostic criteria and outcome definitions
• Document patient privacy safeguards and deidentification

• Specify assay platform, calibration, and QC thresholds
• Report sample timing relative to cycle or treatment
• Provide reference ranges and units for biomarker values
• Describe specimen handling and storage conditions
• Report clinical outcome definitions linked to biomarker analysis
• Include sensitivity analyses for key biomarkers

• Title page with author affiliations and corresponding author details
• Abstract and keywords
• Introduction describing clinical context and research gap
• Methods including assay validation and treatment protocols
• Results with tables, figures, and statistical analysis
• Discussion highlighting implications for clinical care

Provide high resolution figures and editable tables. Ensure all units and abbreviations are defined. Figures should be cited in order and include descriptive captions.

• Cover letter explaining novelty and clinical relevance
• Conflict of interest and funding disclosures
• Ethics approvals and consent documentation
• Data availability statement
• Figure and table files uploaded
• Define the primary biomarker category (hormonal, imaging, genomic, proteomic, or metabolomic).
• Report assay platform, manufacturer, and kit lot numbers where applicable.
• Provide sample collection timing relative to cycle day or stimulation phase.​​

JFB is committed to rigorous, transparent publishing in fertility biomarker research and reproductive medicine. We emphasize reproducible laboratory methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in biomarker validation, reproductive outcomes, and translational fertility science.